Summary

A supplier’s COA reports “HPLC Purity: 99.5%,” while the purchasing specification requires “Assay ≥99.0%.” Can these two values be treated as equivalent?

Usually not.

HPLC area purity indicates the proportion of the main peak area relative to the total area of the peaks included in the calculation under specified chromatographic conditions, detection wavelength, and integration rules. It primarily describes the distribution of chromatographic response rather than the actual weight percentage of the target compound in the sample.

Only when an HPLC method uses a clearly defined quantitative approach, an appropriate reference material, a complete calculation formula, and a specified reporting basis can the result potentially be used as a quantitative assay to determine the actual content of the target compound.

When reviewing a chemical raw material COA, the key question is therefore not whether the HPLC value appears high enough, but:

Does the reported value represent the relative main-peak area, or the calibrated content of the target compound?

HPLC Area Purity and Assay Do Not Measure the Same Attribute

A common HPLC area normalization calculation is:

Main peak area ÷ total area of all included peaks × 100%

This calculation treats the areas of all detected and integrated peaks as the total response and determines the proportion contributed by the main peak. It does not automatically account for:

• differences in detector response among compounds;
• components that are not effectively detected at the selected wavelength;
• small peaks or system peaks excluded from integration;
• water, residual solvents, and inorganic residues;
• impurities coeluting with the main peak;
• salts, hydrates, or solvates present in the sample.

Assay addresses a different question:

How much of the target compound is actually present in the sample?

A chromatographic assay generally requires comparison of the sample response with an appropriately characterized chromatography reference material or another justified quantitative reference. The calculation may also need to account for sample weight, dilution factors, the assigned value of the reference material, and the reporting basis of the result.

Three Types of COA Results Should Not Be Treated as Interchangeable

Buyers should not treat these results as the same quality attribute simply because their numerical values are similar.

Four Types of COA Data That Buyers Commonly Misinterpret

Interpreting “HPLC 99.8%” as “99.8% Assay”

This is one of the most common errors in COA review.

If a batch contains a certain amount of water or residual solvent and these components are not effectively included in the HPLC area-purity calculation, the main peak may still account for more than 99% of the integrated response. However, the actual target-compound content on an as-is basis may be lower than the reported area percentage.

This difference can directly affect:

• the actual number of moles charged in a synthesis;
• catalyst or reagent ratios;
• the amount of active material added to a formulation;
• cost calculations and theoretical yield assessments;
• process reproducibility between batches.

For R&D or production applications that require accurate dosing, area purity should not automatically replace assay data.

Treating “100% Minus the Main Peak Area” as the Total Impurity Content

If the main peak area is 99.5%, the remaining 0.5% usually represents only the chromatographic response of other detected, separated, and integrated peaks.

It does not necessarily mean that impurities account for 0.5% of the sample by weight.

Different compounds may generate different detector responses at the same wavelength. The actual mass of a weakly responding impurity may be higher than its peak area suggests, while a strongly responding impurity may show the opposite effect.

When known impurities differ substantially in structure from the main component, buyers should also confirm whether relative response factors have been evaluated or applied.

Assuming That No Additional Peaks Means No Other Components Are Present

A chromatogram can show only the components that the selected method is able to detect and separate.

A conventional UV-HPLC area result usually cannot independently answer the following questions:

A clean chromatogram therefore indicates only that no obvious additional peaks were observed under the selected test conditions. It should not be extended into a conclusion that no other impurities are present in the sample.

Assuming HPLC Purity Results from Different Suppliers Are Directly Comparable

Two suppliers may both report “HPLC Purity: 99.5%,” but this does not necessarily mean that the two batches have the same quality level.

The result may be affected by differences in:

• detector type and detection wavelength;
• column and mobile-phase conditions;
• gradient program and run time;
• sample concentration;
• peak-integration threshold;
• reporting rules for unknown peaks;
• treatment of solvent and system peaks;
• application of correction factors to known impurities.

When the purity and analytical methods are not aligned, ranking suppliers directly by the reported HPLC percentage may mean comparing two different calculation systems rather than the actual quality of the two batches.

What Information Should Be Checked When Reviewing a COA?

For this specific issue, buyers do not need to repeat a complete review of every quality document. They should focus on the information needed to explain what the HPLC value actually represents.

If a supplier can provide only one HPLC percentage but cannot explain its analytical purpose or calculation basis, the result is more appropriate as a preliminary indication of the chromatographic profile than as a formal assay conclusion.

Sample Qualification and Bulk Procurement Require Different Levels of Evidence

Insufficient area-purity information does not necessarily mean that a material cannot be used. The practical question is which stage of the purchasing decision the available evidence can support.

Exploratory Sample Stage

During early R&D, the material may be used only for:

• preliminary reaction-feasibility testing;
• formulation-direction screening;
• analytical-method development;
• small-scale process observation.

At this stage, a batch-specific COA and a basic HPLC chromatogram may be sufficient to support preliminary testing. However, R&D personnel should understand that this does not mean the raw material has passed formal qualification.

In particular, HPLC area purity should not be entered directly as the effective assay when calculating reaction equivalents unless the analytical method genuinely supports that use.

Formal Sample Qualification Stage

When a sample will be used for process definition, customer testing, or internal raw material qualification, buyers should further confirm:

• the calculation type used for the HPLC result;
• whether a separate assay result is available;
• whether a representative chromatogram is provided;
• whether water and residual solvents affect the intended use;
• whether critical impurities are adequately separated;
• whether the supplier’s method can be reasonably compared with the buyer’s incoming-control method.

At this stage, the question is not only whether the sample performs in a reaction, but also whether the analytical results explain why it performs as observed.

Bulk Procurement and Production Release Stage

Bulk procurement requires greater attention to continued comparability and dosing accuracy.

The following situations are not suitable for bulk quality confirmation based only on the existing COA:

• the purchasing specification requires Assay, but the supplier provides only HPLC area purity;
• HPLC Purity and Assay are reported as the same value without separate calculation support;
• the reporting basis is not defined;
• water or residual solvents may materially affect dosing;
• critical isomers or process-related impurities do not have clearly defined control methods;
• the commercial batch is tested using a different method from the sample batch;
• the reported value is close to the specification limit, but method precision and rounding rules are unclear.

Procurement Status Supported by Different Levels of Evidence

How Should R&D, Quality, and Procurement Teams Interpret the Same COA?

The same HPLC value represents different risks for different functions.

R&D Teams Focus on Dosing Accuracy

R&D personnel primarily need to determine whether the actual raw material content will affect molar ratios, conversion, and experimental reproducibility.

If a raw material has high HPLC area purity but also contains water or solvent, calculating the charge directly from the area percentage may result in an insufficient amount of the target compound being added.

The R&D decision should therefore go beyond whether the chromatogram appears sufficiently pure and determine whether the reported data can support quantitative dosing.

Quality Teams Focus on Whether the Method Is Fit for Its Intended Purpose

Quality personnel need to distinguish among:

• identity methods;
• chromatographic purity methods;
• impurity methods;
• quantitative assay methods.

The same HPLC conditions may not reliably perform all of these tasks. Whether the method can separate critical impurities, uses an appropriate quantitative approach, and defines the reporting basis clearly is more important than the final percentage alone.

Procurement Teams Focus on Whether Supplier Data Are Comparable

Procurement personnel may be inclined to compare prices and suppliers based on values such as 99.5% and 99.8%. However, this comparison is meaningful only when the analytical methods, calculation bases, and supporting specifications are reasonably aligned.

RFQs should require suppliers to define the test item rather than merely provide a higher purity number.

Key Questions to Ask the Supplier

Supplier communication does not need to become a complete analytical-method audit, but the following questions can directly change the purchasing decision:

If these questions cannot be answered at a basic level, “HPLC above 99%” should not be interpreted directly as “effective raw material content above 99%.”

The Core Principle for Reviewing a Chemical Raw Material COA

A concise rule can be applied when reviewing HPLC data:

Unless the supplier can demonstrate that the result was generated using a clearly defined, calibrated method suitable for quantitative analysis, HPLC area purity should be treated as a chromatographic response ratio rather than actual assay.

A COA capable of supporting a purchasing decision should allow the buyer to determine:

1. what the test item measures;
2. how the result is calculated;
3. which peaks are included or excluded;
4. whether response differences among compounds are considered;
5. whether critical impurities are separated from the main peak;
6. which reporting basis is used;
7. whether water and residual solvents are controlled separately.

A high HPLC area-purity value can indicate that the main peak accounts for a concentrated proportion of the chromatographic response under a specified method. It cannot independently prove the actual assay, the total impurity level, or suitability for a particular application.

Before requesting a quotation or confirming a sample, buyers should provide the target specification, application, expected quantity, required Assay or HPLC criteria, reporting basis, chromatogram requirements, water and residual-solvent requirements, and the target market or internal validation standard. Buyers can submit an RFQ to ChemicalCell so that the technical information can be aligned more accurately before sample or commercial-batch confirmation.